Literature DB >> 1689228

Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa.

A Schattner1, M Steinbock, R Tepper, A Schonfeld, N Vaisman, T Hahn.   

Abstract

Fourteen patients with anorexia nervosa (AN) were studied for the production of tumour necrosis factor (TNF), the activation of the interferon (IFN) system and cell-mediated cytotoxicity (CMC) and the results were compared with 16 age-matched healthy women. AN patients had significantly increased spontaneous TNF production by peripheral blood mononuclear cells (PBMC) in vitro (16 +/- 5 U/ml versus 4 +/- 3 U/ml in the control group; P less than 0.05), although no TNF was detectable in the plasma from either group. TNF production in vitro, following stimulation of PBMC by phytohaemagglutinin (PHA) or tumour cells, was similar in AN patients and controls; however, lipopolysaccharide (LPS) induced TNF production was found to be lower in AN (P less than 0.1). CMC was significantly lower in AN patients (4 +/- 2 versus 10 +/- 3 in controls, expressed as lytic units/10(6) cells; P less than 0.05), but no difference could be found between AN and controls in IFN activity as reflected by the level of the IFN-induced enzyme 2'-5' oligoadenylate synthetase (2-5A) in PBMC. Beta-endorphins in the plasma were higher in the AN group (P less than 0.05) but these levels could not be correlated to those of IFN, CMC or TNF. Defective CMC and increased TNF production by PBMC in patients with anorexia nervosa may possibly result from the nutritional deficiencies and neuroendocrine abnormalities associated with the disease, and may contribute to the pathophysiology of AN.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689228      PMCID: PMC1534723          DOI: 10.1111/j.1365-2249.1990.tb05127.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Immunity and depression.

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

Authors:  S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Possible role of natural cytotoxic activity in the pathogenesis of AIDS.

Authors:  T Hahn; A Schattner; Z T Handzel; S Levin; Z Bentwich
Journal:  Clin Immunol Immunopathol       Date:  1989-01

4.  Tumor necrosis factor production during starvation.

Authors:  N Vaisman; A Schattner; T Hahn
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

5.  Monocyte TNF production in gastrointestinal cancer.

Authors:  M Zembala; B Mytar; M Woloszyn; T Popiela; W Uracz; A Czupryna
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

6.  Stress, opioid peptides, the immune system, and cancer.

Authors:  Y Shavit; G W Terman; F C Martin; J W Lewis; J C Liebeskind; R P Gale
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.

Authors:  M E Ostensen; D L Thiele; P E Lipsky
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

Review 8.  Cachectin: a hormone that triggers acute shock and chronic cachexia.

Authors:  K J Tracey; S F Lowry; A Cerami
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

9.  An investigation of the immune response of patients suffering from anorexia nervosa.

Authors:  C A Armstrong-Esther; J H Lacey; A H Crisp; T N Bryant
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

Review 10.  Interferons and autoimmunity.

Authors:  A Schattner
Journal:  Am J Med Sci       Date:  1988-06       Impact factor: 2.378

View more
  6 in total

1.  Evidence for a positive correlation between serum cortisol levels and IL-1beta production by peripheral mononuclear cells in anorexia nervosa.

Authors:  P Limone; A Biglino; F Bottino; B Forno; P Calvelli; S Fassino; C Berardi; P Ajmone-Catt; A Bertagna; R P Tarocco; G G Rovera; G M Molinatti
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

2.  Low lymphocyte interferon-gamma production and variable proliferative response in anorexia nervosa patients.

Authors:  E Polack; V E Nahmod; E Emeric-Sauval; M Bello; M Costas; S Finkielman; E Arzt
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

Review 3.  Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

Authors:  H Van Loveren; J G Van Amsterdam; R J Vandebriel; T G Kimman; H C Rümke; P S Steerenberg; J G Vos
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

4.  Reduced natural killer cell activity and IL-2 production in malnourished cancer patients.

Authors:  M L Villa; E Ferrario; E Bergamasco; F Bozzetti; L Cozzaglio; E Clerici
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

Review 5.  Immune disorders in anorexia.

Authors:  Sylwia Małgorzata Słotwińska; Robert Słotwiński
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

Review 6.  Anorexia Nervosa and the Immune System-A Narrative Review.

Authors:  Dennis Gibson; Philip S Mehler
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.